返回
Ionic-Liquid-Based Safe Adjuvants
DOI:10.1002/adma.202002990.png)
摘要
En 中文
Adjuvants play a critical role in the design and development of novel vaccines. Despite extensive research, only a handful of vaccine adjuvants have been approved for human use. Currently used adjuvants are mostly composed of components that are non-native to the human body, such as aluminum salt, bacterial lipids, or foreign genomic material. Here, a new ionic-liquid-based adjuvant is explored, synthesized using two metabolites of the body, choline and lactic acid (ChoLa). ChoLa distributes the antigen efficiently upon injection, maintains antigen integrity, enhances immune infiltration at the injection site, and leads to a potent immune response against the antigen. Thus, it can serve as a promising safe adjuvant platform that can help to protect against pandemics and future infectious threats.
Keyword:
adjuvants
choline
immune modulation
ionic liquids
lactic acid
vaccines
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
26.8
论文数:
3.5W
被引数:
46.0W
机构
引用论文
Design Principles of Ionic Liquids for Transdermal Drug Delivery离子液体经皮给药的设计原则
ADVANCED MATERIALS
IF26.8
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
NPJ VACCINES
IF6.5

